Skip to main content
Clinical Trials/TCTR20211204002
TCTR20211204002
Completed
Phase 4

The study to compare the immune response between intradermal and intramuscular injection of botulinum toxin A; Prospective study

Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand0 sites100 target enrollmentDecember 4, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Healthy human volunteers
Sponsor
Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand
Enrollment
100
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 4, 2021
End Date
May 17, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy male or female volunteers age 25\-45 years, 2\. No history of botulinum toxin treatment failure, 3\. No history of immunodeficiency disease or taking any immunosuppressive drug,

Exclusion Criteria

  • 1\. pregnant or lactating woman, 2\. Was treated with botulinum toxin during 6 months prior, 3\. Having the skin disease around the treated area

Outcomes

Primary Outcomes

Not specified

Similar Trials